Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3-10 ng/ml

International Urology and Nephrology

Volumn 38, Issue 3-4, 2006, Pages 553-557

  Elabbady, Ahmed A ^a   Khedr, Mahrousa M ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Free total PSA; Gleason score; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION COEFFICIENT; GLEASON SCORE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PREDICTION; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY;

HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33847356500     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-6672-5     Document Type: Article

References (17)

1. Landis SH, Murray T, Bolden S and Wingo PA (1999). Cancer statistics, 1999. CA Cancer J Clin 49(31): 8-31
2. Sokoloff MH, Yang XJ, Fumo M, Mhoon D and Brendler CB (2004). Characterizing prostatic adenocarcinomas im men with a serum prostate specific antigen level of <4.0 ng/ml. Br J Urol 93(4): 499-502
3. Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L and Leinonen J (1994). Serum concentration of prostate specific antigen and its complex with alpha 1-antichymotripsin before diagnosis of prostate cancer. Lancet 344: 1594-1598
4. Partin AW, Catalona WJ and Southwick PC (1996). Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age. Urology 48: 55
5. Akdas A, Cevik I, Turkeri L, Dalaman G and Emerk K (1997). The role of free prostate- specific antigen in the diagnosis of prostate cancer. Br J Urol 79(6): 920-923
6. Shah JB, Reese AC, McKiernan JM and Benson MC (2005). PSA updated: Still relevant in the new millennium. Eur Urol 47: 427-432
7. Woodrum D, French C and Shamel LB (1996). Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions. Urology 48: 33
8. Pannek J, Rittenhouse HG and Chan DW (1998). The use of percent free prostate specific antigen for staging clinically localized prostate cancer. J Urol 159: 1238
9. Grossklaus DJ, Coffey CS and Shappel SB (2001). Percent free PSA is reflective of prostate cancer pathology in surgical specimen. J Urol 165(5): 282
10. Berger A, Klocker H, Niescher M, Bektie J, Pelzer A, Bartsch G and Hominger W (2005). Prostate cancer detection rates in the low and intermediate PSA range. Eur Urol (Supplements) 4(3): 597
11. Okegawa T, Kato M, Nutahara K and Higashihara E (2001). Prognostic value of three molecular forms of prostate-specific antigen ratios in patients with prostate adenocarcinoma. Urology 57(5): 936-942
12. Egawa S, Suyama K, Soh S, Kuwao S, Uchida T and Koshiba K (1998). Inadequacy of free prostate-specific antigen parameters in the prediction of pathologic extent of prostate cancer in Japanese men. Urology 52(2): 230-236
13. Graefen M, Karakiewicz PI and Scardino P (2001). Percentage of free PSA is not an independent predictor of pathologic stage or PSA recurrence in patients with localized prostate cancer treated with radical prostatectomy. J Urol 165(5): 281
14. Tombal B, Querton M, Sauvage P, Cosyns J-P, Feyaerts A, Opsomer R, Wese F, Cangh P and Nayer P (2002). Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy. Urology 59(2): 256-260
15. Djavan B, Kadesky K, Klopukh B, Marberger M and Roehrborn CG (1998). Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur Urol 33: 261-270
16. Emilozzi P, Maymone S, Paterno A, Scarpone P, Amini M, Proietti G, Cordahi M and Pansadoro V (2004). Increased accuracy of biopsy Glaeson score obtained by extended needle biopsy. J Urol 172: 2224-2226
17. Johnstone PA, Riffenburgh R, Saunders EL and Willison FW (1995). Grading inaccuracies in diagnostic biopsies revealing prostatic adenocarcinoma: implications for definitive radiation therapy. Int J Radiat Oncol Biol Phys 32: 479-482